To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene COL11A1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
242 supporting clones for gene COL11A1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_080629.2   .a 1 to 7327 1 to 7327 exact RefSeq,   7327/7327
(100 %)
0 diff
(100 %id)
AW067903 Bone, Hip .a 13 to 383 3 to 377   tiling clone,   375/377
(99 %)
6 diff
(98.5 %id)
BX097890 senescent fibroblast .a 31 to 510 1 to 480   tiling clone,   480/480
(100 %)
0 diff
(100 %id)
AI168065 senescent fibroblast .a 870 to 1096 226 to 1   tiling clone,   226/226
(100 %)
9 diff
(96.1 %id)
AW068361 Bone, Hip .a 1317 to 1768 462 to 11   tiling clone,   452/462
(97 %)
0 diff
(100 %id)
CN367007 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1369 to 1926 1 to 558       558/566
(98 %)
1 diff
(99.9 %id)
CN367009 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1530 to 1842 1 to 313       313/313
(100 %)
5 diff
(98.5 %id)
CN367010 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1539 to 2039 1 to 501   tiling clone,   501/501
(100 %)
5 diff
(99.1 %id)
BQ311158 breast_normal .a 1667 to 1919 253 to 1       253/266
(95 %)
2 diff
(99.3 %id)
BQ311159 breast_normal .a 1667 to 1919 253 to 1       253/267
(94 %)
1 diff
(99.7 %id)
BQ311160 breast_normal .a 1667 to 1924 267 to 10       258/267
(96 %)
1 diff
(99.7 %id)
CN367004 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1695 to 1966 1 to 272       272/272
(100 %)
0 diff
(100 %id)
BE011998 breast_normal .a 1758 to 1919 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
BE011999 breast_normal .a 1758 to 1919 1 to 162       162/162
(100 %)
0 diff
(100 %id)
CN367006 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2312 to 2813 1 to 502   tiling clone,   502/502
(100 %)
2 diff
(99.7 %id)
AI750286 Bone, Hip .a 2377 to 2740 9 to 372   tiling clone,   364/372
(97 %)
6 diff
(98.4 %id)
CD613055   .a 2683 to 3188 12 to 517       506/518
(97 %)
7 diff
(98.7 %id)
CD613056   .a 2683 to 3188 501 to 2   tiling clone,   500/512
(97 %)
8 diff
(98.5 %id)
BM833209 stomach .a 2799 to 3258 1 to 460   tiling clone,   460/460
(100 %)
0 diff
(100 %id)
AI750287 Bone, Hip .a 2995 to 3369 382 to 8       375/382
(98 %)
0 diff
(100 %id)
AI750430 Bone, Hip .a 3123 to 3390 9 to 276       268/276
(97 %)
8 diff
(97.2 %id)
AI751131 Bone, Hip .a 3123 to 3724 9 to 615   tiling clone,   607/616
(98 %)
19 diff
(97.0 %id)
CA392383 eye, RPE/choroid .a 3279 to 3690 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BG819340 anaplastic oligodendroglioma with 1p/19qloss, brain .a 3498 to 4201 1 to 710       710/724
(98 %)
17 diff
(97.7 %id)
AI926176 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3500 to 3976 475 to 1       475/475
(100 %)
4 diff
(99.2 %id)
AA333515 Embryo, 8 weeks .a 3580 to 3875 1 to 299       299/299
(100 %)
6 diff
(98.0 %id)
BE395287 endometrium, adenocarcinoma cell line, uterus .a 3600 to 4243 1 to 642   tiling clone,   642/646
(99 %)
12 diff
(98.2 %id)
BQ311442 breast_normal .a 3872 to 4222 1 to 349       349/349
(100 %)
6 diff
(98.3 %id)
BQ311367 breast_normal .a 3873 to 4263 8 to 398       391/398
(98 %)
8 diff
(98.0 %id)
BX476821   .a 4036 to 4504 1 to 469   tiling clone,   469/469
(100 %)
0 diff
(100 %id)
BY797330 eye .a 4037 to 4632 1 to 596       596/596
(100 %)
2 diff
(99.7 %id)
AA333343 Embryo, 8 weeks .a 4194 to 4475 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
DR762890 embryonic stem .a 4353 to 5166 1 to 814   tiling clone,   814/814
(100 %)
3 diff
(99.7 %id)
AA331605 Embryo, 8 weeks .a 4496 to 4809 1 to 316       316/316
(100 %)
4 diff
(98.8 %id)
AA331862 Embryo, 8 weeks .a 4496 to 4764 1 to 269       269/269
(100 %)
0 diff
(100 %id)
ES309285 occipital hair of pubic hypotrichosispatient, skin .a 4577 to 5216 30 to 663       634/864
(73 %)
26 diff
(97.0 %id)
CN367008 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4608 to 5317 9 to 718       710/718
(98 %)
8 diff
(98.9 %id)
BM698024 eye, fetal eyes .a 4766 to 5067 1 to 302       302/302
(100 %)
2 diff
(99.4 %id)
BU159588 epithelioid carcinoma, Pancreas .a 4810 to 5666 1 to 858   tiling clone,   858/858
(100 %)
2 diff
(99.8 %id)
BU170754 epithelioid carcinoma, Pancreas .a 4810 to 5569 1 to 763       763/763
(100 %)
3 diff
(99.7 %id)
AW452590   .a 4818 to 5316 508 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 499/529
(94 %)
3 diff
(99.5 %id)
AA327960   .a 4913 to 5187 1 to 275       275/275
(100 %)
2 diff
(99.3 %id)
ES315239 occipital scalp hair, skin .a 5023 to 5162 1 to 140       140/140
(100 %)
0 diff
(100 %id)
AU119603 whole embryo, mainly head .a 5023 to 5824 2 to 803   capped   802/802
(100 %)
14 diff
(98.3 %id)
ES312176 frontal balding hair, skin .a 5040 to 5230 1 to 191       191/202
(94 %)
1 diff
(99.6 %id)
AK299025   .a 5104 to 6169 1 to 1066       1066/1066
(100 %)
1 diff
(100.0 %id)
DC368917   .a 5104 to 5434 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
AW363705 colon .a 5111 to 5478 1 to 369       369/370
(99 %)
8 diff
(97.9 %id)
ES312112 frontal balding hair, skin .a 5112 to 5292 1 to 181       181/181
(100 %)
0 diff
(100 %id)
AW363699 colon .a 5116 to 5472 358 to 1       358/364
(98 %)
2 diff
(99.5 %id)
BF838996 head_neck .a 5127 to 5661 10 to 545       536/545
(98 %)
10 diff
(98.2 %id)
BF844134 head_neck .a 5127 to 5541 21 to 433       413/433
(95 %)
13 diff
(97.0 %id)
ES315157 occipital scalp hair, skin .a 5220 to 5386 1 to 166       166/166
(100 %)
3 diff
(98.2 %id)
TI_154130827   .a 5221 to 6064 916 to 85   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 832/923
(90 %)
22 diff
(97.7 %id)
AA332568 Embryo, 8 weeks .a 5290 to 5594 1 to 307       307/307
(100 %)
5 diff
(98.4 %id)
BE926438 breast .a 5308 to 5944 1 to 633       638/641
(99 %)
15 diff
(97.7 %id)
AA328825   .a 5313 to 5552 1 to 240       240/240
(100 %)
0 diff
(100 %id)
BQ574826 Chondrosarcoma Grade II, Left Pelvis .a 5326 to 6064 753 to 15   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 739/739
(100 %)
1 diff
(99.9 %id)
BQ774443 Chondrosarcoma Grade II, Left Pelvis .a 5327 to 6064 751 to 14   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 738/738
(100 %)
5 diff
(99.4 %id)
BF970469 adrenal cortex carcinoma, cell line, adrenal gland .a 5328 to 6057 1 to 733       733/916
(80 %)
15 diff
(98.4 %id)
CX870378 embryonic stem .a 5351 to 6231 1 to 879   tiling clone,   879/879
(100 %)
6 diff
(99.4 %id)
BX109171 melanocyte .a 5356 to 5912 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BM721717 eye, fetal eye .a 5358 to 5719 1 to 362       362/362
(100 %)
0 diff
(100 %id)
H96772 melanocyte .a 5366 to 5738 1 to 385       385/459
(83 %)
25 diff
(94.6 %id)
AW368412 head_neck .a 5426 to 5628 1 to 203       203/204
(99 %)
3 diff
(98.6 %id)
AW368414 head_neck .a 5433 to 5628 1 to 196       196/197
(99 %)
3 diff
(98.5 %id)
R31744 placenta .a 5622 to 5928 3 to 319       317/417
(76 %)
15 diff
(96.5 %id)
BU753538 placenta .a 5628 to 6309 699 to 18   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 682/685
(99 %)
1 diff
(99.9 %id)
AW244095 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a 5629 to 6064 436 to 1       436/464
(93 %)
6 diff
(98.8 %id)
BF840253 head_neck .a 5632 to 6026 1 to 396       396/396
(100 %)
15 diff
(96.3 %id)
AI358777 adenocarcinoma, Pancreas .a 5637 to 6068 431 to 1       431/431
(100 %)
8 diff
(98.2 %id)
R67275 whole brain .a 5645 to 6071 440 to 2       439/441
(99 %)
0 diff
(100 %id)
BF840254 head_neck .a 5649 to 6026 1 to 383       383/383
(100 %)
24 diff
(93.8 %id)
CA420980 Bone, Enchondroma cell line .a 5652 to 6309 676 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 658/658
(100 %)
2 diff
(99.7 %id)
DV460025 cochlea, ear .a 5653 to 5899 248 to 2     Submitted on the opposite strand 247/250
(98 %)
0 diff
(100 %id)
AI750431 Bone, Hip .a 5667 to 6046 387 to 8       380/387
(98 %)
0 diff
(100 %id)
BQ574107 Chondrosarcoma Grade II, Left Pelvis .a 5673 to 6353 699 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 681/681
(100 %)
0 diff
(100 %id)
CA418862 Chondrosarcoma Grade II, Left Pelvis .a 5674 to 6075 405 to 1       405/405
(100 %)
4 diff
(99.1 %id)
BI491893 cochlea, ear .a 5683 to 6263 581 to 1       581/581
(100 %)
0 diff
(100 %id)
AI753167 bone marrow stroma .a 5685 to 6064 398 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
AI140415 heart .a 5685 to 6172 489 to 2       488/489
(99 %)
0 diff
(100 %id)
DV459265 cochlea, ear .a 5688 to 5895 1 to 208       208/208
(100 %)
2 diff
(99.1 %id)
DV462673 cochlea, ear .a 5688 to 5899 212 to 1     Submitted on the opposite strand 212/212
(100 %)
1 diff
(99.6 %id)
R52907 whole brain .a 5689 to 6057 369 to 1       369/374
(98 %)
2 diff
(99.5 %id)
AI832237 colon, colon tumor, RER+ .a 5689 to 6171 484 to 1       484/484
(100 %)
2 diff
(99.6 %id)
BQ009513 Chondrosarcoma, Left Pubic Bone .a 5697 to 6359 681 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
TI_154053671   .a 5705 to 6314 706 to 97   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 610/982
(62 %)
0 diff
(100 %id)
CA415617 Chondrosarcoma Grade II, Left Pelvis .a 5705 to 6314 628 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 610/619
(98 %)
0 diff
(100 %id)
BM667191 eye, fetal eyes .a 5827 to 6293 475 to 9       467/475
(98 %)
0 diff
(100 %id)
H96237 melanocyte .a 6089 to 6283 195 to 1       195/195
(100 %)
4 diff
(98.0 %id)
DB358063 whole embryo, mainly head .a 6756 to 7320 558 to 1   tiling clone,   558/562
(99 %)
27 diff
(95.2 %id)
R31701 placenta .a 7119 to 7286 170 to 1       170/170
(100 %)
6 diff
(96.5 %id)
NM_001854.3   .b 1 to 7291 1 to 7291 exact RefSeq,   7291/7291
(100 %)
0 diff
(100 %id)
J04177   .b 158 to 6322 1 to 6157 Y758X E809X K941R D942M L944C ... tiling clone,   6157/6158
(99 %)
46 diff
(99.3 %id)
CN367005 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 723 to 1396 1 to 674       674/674
(100 %)
0 diff
(100 %id)
NM_001190709.1   .c 1 to 7173 1 to 7173 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 7173/7173
(100 %)
0 diff
(100 %id)
NM_080630.3   .d 1 to 6942 1 to 6942 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 6942/6942
(100 %)
0 diff
(100 %id)
BC117697 PCR rescued clones .d 18 to 5459 1 to 5442 P1207L S1419P tiling clone,   5442/5450
(99 %)
5 diff
(100.0 %id)
AB208844 brain .e 1 to 5289 1 to 5289 P519L S731P tiling clone,   5289/5289
(100 %)
4 diff
(100.0 %id)
W30725 senescent fibroblast .e 4467 to 4781 1 to 318       318/318
(100 %)
5 diff
(98.5 %id)
BQ574180 Chondrosarcoma Grade II, Left Pelvis .e 4683 to 5057 380 to 6       375/380
(98 %)
0 diff
(100 %id)
AU118365 whole embryo, mainly head .e 4698 to 5516 2 to 816   tiling clone, capped   815/818
(99 %)
8 diff
(99.1 %id)
AI096671 uterus .e 4705 to 5145 441 to 1       441/450
(98 %)
0 diff
(100 %id)
AI276237 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 4705 to 5145 442 to 1       442/444
(99 %)
1 diff
(99.8 %id)
TI_157609581   .e 4711 to 5273 656 to 94       563/657
(85 %)
0 diff
(100 %id)
AW024038.
matches multiple genes
cochlea, ear, Prostate .e 4721 to 5090 7 to 376     also hits gene masare 370/376
(98 %)
6 diff
(98.5 %id)
AI042579 senescent fibroblast .e 4731 to 5289 567 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 557/557
(100 %)
3 diff
(99.5 %id)
AA334620   .e 4739 to 5022 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
AA577553 colon, colon tumor .e 4741 to 5336 591 to 2       590/595
(99 %)
0 diff
(100 %id)
BQ004923 Chondrosarcoma, Left Pelvis .e 4748 to 5289 560 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 542/542
(100 %)
4 diff
(99.3 %id)
AA587851 adrenal adenoma, adrenal gland .e 4749 to 5291 543 to 1       543/565
(96 %)
18 diff
(96.9 %id)
AI147586 uterus .e 4755 to 5145 384 to 1       384/400
(96 %)
19 diff
(95.3 %id)
AI688784 colon .e 4766 to 5334 565 to 1       565/565
(100 %)
7 diff
(98.8 %id)
CF529910 placenta .e 4769 to 5273 520 to 16       505/520
(97 %)
0 diff
(100 %id)
AI038531   .e 4770 to 5336 573 to 8       566/573
(98 %)
0 diff
(100 %id)
DV459363 cochlea, ear .e 4785 to 4875 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
AI074420 senescent fibroblast .e 4794 to 5290 501 to 5       497/501
(99 %)
0 diff
(100 %id)
BE762866 nervous_tumor .e 4804 to 5135 43 to 373       331/373
(88 %)
7 diff
(98.2 %id)
BQ004959 Chondrosarcoma, Left Pelvis .e 4807 to 5334 545 to 18       528/545
(96 %)
0 diff
(100 %id)
BM832836 stomach .e 4813 to 5287 1 to 475       475/475
(100 %)
0 diff
(100 %id)
CA414460 Chondrosarcoma Grade II, Left Pelvis .e 4825 to 5333 531 to 23       509/531
(95 %)
0 diff
(100 %id)
TI_151709323.
matches multiple genes
  .e 4832 to 5041 312 to 103   AAA also hits gene kustar 210/216
(97 %)
0 diff
(100 %id)
CA414600 Chondrosarcoma Grade II, Left Pelvis .e 4838 to 5289 470 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
AA330510   .e 4852 to 5039 1 to 188       188/188
(100 %)
0 diff
(100 %id)
AI041918 senescent fibroblast .e 4852 to 5296 446 to 2       445/446
(99 %)
0 diff
(100 %id)
CA413588 Chondrosarcoma Grade II, Left Pelvis .e 4855 to 5286 450 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 432/432
(100 %)
4 diff
(99.1 %id)
DV461487 cochlea, ear .e 4873 to 5105 9 to 240       232/240
(96 %)
6 diff
(97.5 %id)
DV462778 cochlea, ear .e 4874 to 5105 13 to 244       232/244
(95 %)
6 diff
(97.6 %id)
DV462586 cochlea, ear .e 4876 to 5105 1 to 230       230/230
(100 %)
0 diff
(100 %id)
DV459262 cochlea, ear .e 4876 to 5105 1 to 230       230/230
(100 %)
0 diff
(100 %id)
DV460326 cochlea, ear .e 4876 to 5105 1 to 230       230/230
(100 %)
0 diff
(100 %id)
DV462442 cochlea, ear .e 4876 to 5105 230 to 1     Submitted on the opposite strand 230/230
(100 %)
0 diff
(100 %id)
DV460775 cochlea, ear .e 4876 to 5107 243 to 12     Submitted on the opposite strand 232/243
(95 %)
0 diff
(100 %id)
AI040800   .e 4877 to 5294 416 to 1       416/497
(83 %)
20 diff
(96.0 %id)
DV462579 cochlea, ear .e 4878 to 5105 228 to 1     Submitted on the opposite strand 228/232
(98 %)
2 diff
(99.2 %id)
BM757815 stomach .e 4883 to 5289 1 to 404       404/404
(100 %)
1 diff
(99.8 %id)
CA414536 Chondrosarcoma Grade II, Left Pelvis .e 4883 to 5339 475 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
DV460262 cochlea, ear .e 4884 to 5105 222 to 1     Submitted on the opposite strand 222/222
(100 %)
2 diff
(99.1 %id)
AW496801   .e 4886 to 5029 144 to 1       144/144
(100 %)
0 diff
(100 %id)
AW022167 cochlea, ear .e 4891 to 5057 9 to 175       167/180
(92 %)
2 diff
(98.9 %id)
N64155 cochlea, ear .e 4922 to 5043 122 to 1       122/122
(100 %)
0 diff
(100 %id)
BQ011666 placenta .e 4922 to 5289 387 to 20   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 368/368
(100 %)
2 diff
(99.5 %id)
DV460090 cochlea, ear .e 4929 to 5104 177 to 2     Submitted on the opposite strand 176/177
(99 %)
0 diff
(100 %id)
N68250 cochlea, ear .e 4941 to 5290 351 to 2       350/351
(99 %)
0 diff
(100 %id)
AI688588 colon .e 4948 to 5333 408 to 23   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 386/386
(100 %)
1 diff
(99.8 %id)
N64575 cochlea, ear .e 4950 to 5334 394 to 8       387/394
(98 %)
0 diff
(100 %id)
H89889 cochlea, ear .e 4953 to 5269 1 to 331   AAA   331/359
(92 %)
17 diff
(95.3 %id)
AW023361 cochlea, ear .e 4959 to 5289 1 to 331   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 331/331
(100 %)
4 diff
(98.8 %id)
AW020405 cochlea, ear .e 5031 to 5335 1 to 305   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 305/305
(100 %)
5 diff
(98.4 %id)
AW243669 adenocarcinoma, Pancreas .e 5057 to 5267 211 to 1       211/211
(100 %)
2 diff
(99.1 %id)
AA852652 Bone, Hip .e 5081 to 5382 1 to 302       302/302
(100 %)
4 diff
(98.7 %id)
CA447865 Chondrosarcoma, Left Pelvis .e 5090 to 5289 219 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 201/236
(85 %)
6 diff
(97.5 %id)
BI493426 cochlea, ear .e 5121 to 5339 1 to 219   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 219/219
(100 %)
5 diff
(97.8 %id)
DV460197 cochlea, ear .e 5146 to 5334 208 to 20     Submitted on the opposite strand 189/208
(90 %)
0 diff
(100 %id)
N66415 cochlea, ear .e 5147 to 5336 190 to 1       190/196
(96 %)
0 diff
(100 %id)
H89045 cochlea, ear .e 5148 to 5336 1 to 189       189/189
(100 %)
0 diff
(100 %id)
BI493425 cochlea, ear .e 5166 to 5282 117 to 1   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 117/117
(100 %)
0 diff
(100 %id)
T28202 colon, embryo .e 5172 to 5335 1 to 164       164/164
(100 %)
0 diff
(100 %id)
AA460876   .e 5316 to 5805 1 to 490   tiling clone,   490/490
(100 %)
8 diff
(98.4 %id)
TI_154113007   .e 5367 to 6306 1012 to 87   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 926/964
(96 %)
18 diff
(98.2 %id)
TI_154051017   .e 5372 to 6300 1002 to 88   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 915/1013
(90 %)
21 diff
(98.0 %id)
BG110877 Bone, osteosarcoma, cell line .e 5475 to 6102 1 to 633       633/783
(80 %)
10 diff
(98.8 %id)
TI_154047750   .e 5536 to 6301 884 to 127       758/1065
(71 %)
0 diff
(100 %id)
BQ008905 Chondrosarcoma, Left Pelvis .e 5560 to 6300 759 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 741/741
(100 %)
0 diff
(100 %id)
CA448616 Chondrosarcoma, Left Pelvis .e 5584 to 6306 741 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 723/723
(100 %)
0 diff
(100 %id)
CA414254 Chondrosarcoma Grade II, Left Pelvis .e 5585 to 6300 734 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 716/716
(100 %)
0 diff
(100 %id)
BQ771691 Chondrosarcoma Grade II, Left Pelvis .e 5591 to 6300 728 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 710/710
(100 %)
1 diff
(99.9 %id)
CA411948 Chondrosarcoma Grade II, Left Pelvis .e 5594 to 6300 725 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 707/707
(100 %)
1 diff
(99.9 %id)
TI_154103670   .e 5612 to 6300 777 to 95   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 683/789
(86 %)
28 diff
(96.5 %id)
CA411719 Chondrosarcoma Grade II, Left Pelvis .e 5615 to 6297 700 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 682/682
(100 %)
1 diff
(99.9 %id)
BQ009532 Chondrosarcoma, Left Pubic Bone .e 5619 to 6300 700 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 682/682
(100 %)
0 diff
(100 %id)
CA413827 Chondrosarcoma Grade II, Left Pelvis .e 5669 to 6300 651 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 633/636
(99 %)
5 diff
(99.3 %id)
BQ003745 Chondrosarcoma, Left Pelvis .e 5685 to 6300 633 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 615/615
(100 %)
10 diff
(98.4 %id)
BG028597 Bone, osteosarcoma, cell line .e 5698 to 6300 13 to 615   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 603/615
(98 %)
6 diff
(99.1 %id)
BF589336 pooled .e 5736 to 6297 567 to 6       562/567
(99 %)
0 diff
(100 %id)
AA526911 breast .e 5756 to 6300 568 to 22   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 547/548
(99 %)
26 diff
(95.3 %id)
DV462816 cochlea, ear .e 5760 to 6305 568 to 30     Submitted on the opposite strand 539/572
(94 %)
0 diff
(100 %id)
N66493 cochlea, ear .e 5777 to 6301 530 to 1       530/530
(100 %)
27 diff
(95.0 %id)
AA460702   .e 5837 to 6301 471 to 7       465/472
(98 %)
0 diff
(100 %id)
N99064 senescent fibroblast .e 5853 to 6307 443 to 5       439/540
(81 %)
0 diff
(100 %id)
BU753211 placenta .e 5853 to 6306 472 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 454/454
(100 %)
4 diff
(99.2 %id)
AU144951 whole embryo, mainly head .e 5879 to 6300 422 to 1       422/425
(99 %)
7 diff
(98.4 %id)
CA445893 Chondrosarcoma, Left Pelvis .e 5894 to 6300 425 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 407/407
(100 %)
0 diff
(100 %id)
AI377429   .e 5928 to 6307 382 to 3   tiling clone,   380/382
(99 %)
0 diff
(100 %id)
AA852651 Bone, Hip .e 6008 to 6299 311 to 20   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 292/292
(100 %)
1 diff
(99.7 %id)
AI380976 B-cell, chronic lymphotic leukemia .e 6019 to 6301 285 to 3       283/285
(99 %)
0 diff
(100 %id)
AI306727 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 6049 to 6300 266 to 15   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 252/252
(100 %)
0 diff
(100 %id)
AA883622 pooled .e 6060 to 6300 241 to 1       241/241
(100 %)
0 diff
(100 %id)
N66519 cochlea, ear .e 6227 to 6301 75 to 1       75/75
(100 %)
0 diff
(100 %id)
Z43482 brain, total brain .f 1 to 340 1 to 340   tiling clone,   340/340
(100 %)
1 diff
(99.8 %id)
R14659 whole brain .f 2 to 435 1 to 444   tiling clone,   444/461
(96 %)
19 diff
(95.9 %id)
R52906 whole brain .f 2 to 238 1 to 237   tiling clone,   237/237
(100 %)
0 diff
(100 %id)
F02844 brain, total brain .f 1390 to 1730 340 to 1   tiling clone,   340/340
(100 %)
1 diff
(99.8 %id)
R45637 whole brain .f 1396 to 1742 362 to 3   tiling clone,   360/440
(81 %)
0 diff
(100 %id)
TI_154054624   .g 1 to 846 941 to 96 D4I V5T L6K K7A A8L ... tiling clone, AAA   844/972
(86 %)
19 diff
(98.1 %id)
BQ575402 Chondrosarcoma Grade II, Left Pelvis .g 114 to 846 747 to 19   tiling clone, AAA   729/729
(100 %)
4 diff
(99.5 %id)
CA418461 Chondrosarcoma Grade II, Left Pelvis .g 217 to 846 648 to 19   AAA   630/630
(100 %)
1 diff
(99.9 %id)
AI168064 senescent fibroblast .g 445 to 887 453 to 11   AAA   443/443
(100 %)
1 diff
(99.8 %id)
AI167334 senescent fibroblast .g 447 to 889 448 to 6   tiling clone,   443/448
(98 %)
0 diff
(100 %id)
AI168054 senescent fibroblast .g 454 to 887 446 to 13   AAA   434/434
(100 %)
1 diff
(99.8 %id)
BQ448233 Knee, Osteoarthritic Cartilage .h 1 to 677 692 to 17 G5V D6I P7Q G8V P9L ... tiling clone, AAA   676/676
(100 %)
2 diff
(99.8 %id)
BU623366 cell lines, Enchondroma .h 30 to 677 664 to 17   tiling clone, AAA   648/650
(99 %)
2 diff
(99.7 %id)
BQ773729 Chondrosarcoma Grade II, Left Pelvis .i 1 to 766 782 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 764/769
(99 %)
3 diff
(99.7 %id)
BQ003209 Chondrosarcoma, Left Pelvis .i 98 to 766 682 to 14 exact AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 669/669
(100 %)
2 diff
(99.8 %id)
BQ771637 Chondrosarcoma Grade II, Left Pelvis .i 108 to 779 672 to 1 exact     672/672
(100 %)
2 diff
(99.8 %id)
BU628362 Bone, Enchondroma cell line .i 109 to 766 676 to 19 exact AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 658/658
(100 %)
0 diff
(100 %id)
AW367727 head_neck .i 124 to 642 555 to 37 V2A M4R     519/555
(93 %)
2 diff
(99.7 %id)
TI_154046645   .i 124 to 1016 959 to 79 V2A Q3M M4T T5S F6* AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 881/1006
(87 %)
17 diff
(98.4 %id)
AW022652 cochlea, ear .i 125 to 557 87 to 519 exact     433/519
(83 %)
6 diff
(98.9 %id)
CA413902 Chondrosarcoma Grade II, Left Pelvis .i 126 to 766 659 to 19 exact AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 641/641
(100 %)
0 diff
(100 %id)
CA419181 Chondrosarcoma Grade II, Left Pelvis .i 126 to 766 659 to 19 exact AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 641/641
(100 %)
0 diff
(100 %id)
AI949315 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 136 to 773 639 to 3       637/639
(99 %)
4 diff
(99.4 %id)
AW771186 colon, juvenile granulosa tumor .i 146 to 766 621 to 1       621/621
(100 %)
0 diff
(100 %id)
BU179650 melanotic melanoma, cell line, skin .i 153 to 766 1 to 614   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BU839402 melanotic melanoma, cell line, skin .i 153 to 766 1 to 614   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BU196843 melanotic melanoma, cell line, skin .i 153 to 766 1 to 614   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BQ681463 melanotic melanoma, cell line, skin .i 153 to 766 1 to 614   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BQ677134 melanotic melanoma, cell line, skin .i 153 to 766 1 to 614   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BQ448578 Knee, Osteoarthritic Cartilage .i 168 to 777 611 to 1       611/611
(100 %)
3 diff
(99.6 %id)
BQ573908 Chondrosarcoma Grade II, Left Pelvis .i 168 to 779 613 to 1       613/613
(100 %)
3 diff
(99.6 %id)
TI_154109359   .i 170 to 1011 933 to 95   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 839/977
(85 %)
11 diff
(98.9 %id)
BQ774453 Chondrosarcoma Grade II, Left Pelvis .i 193 to 766 592 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 574/574
(100 %)
0 diff
(100 %id)
AW020935.
matches multiple genes
cochlea, ear .i 195 to 495 8 to 308     Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base), also hits gene RFX7 301/308
(97 %)
6 diff
(98.1 %id)
AA604936 adrenal adenoma, adrenal gland .i 208 to 765 558 to 1       558/558
(100 %)
0 diff
(100 %id)
AA883432 pooled .i 212 to 761 546 to 1       546/546
(100 %)
25 diff
(95.5 %id)
TI_154046653   .i 219 to 1055 913 to 89   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 825/981
(84 %)
14 diff
(98.6 %id)
AW631185 pooled .i 224 to 760 537 to 1       537/537
(100 %)
19 diff
(96.5 %id)
CA447834 Chondrosarcoma, Left Pelvis .i 228 to 1011 802 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 784/784
(100 %)
2 diff
(99.8 %id)
BF837365 head_neck .i 233 to 645 414 to 9     Submitted on the opposite strand 406/414
(98 %)
0 diff
(100 %id)
AA565860 adrenal adenoma, adrenal gland .i 241 to 766 525 to 1       525/525
(100 %)
1 diff
(99.9 %id)
BE067787 breast .i 244 to 457 214 to 1     Submitted on the opposite strand 214/214
(100 %)
3 diff
(98.6 %id)
AA622554 germ cell tumor .i 266 to 766 501 to 1       501/501
(100 %)
0 diff
(100 %id)
BQ007639 Chondrosarcoma, Left Pelvis .i 270 to 1061 809 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 791/791
(100 %)
3 diff
(99.7 %id)
TI_154052258   .i 276 to 1057 868 to 91   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 778/962
(80 %)
8 diff
(99.2 %id)
CA414298 Chondrosarcoma Grade II, Left Pelvis .i 276 to 1011 753 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 735/735
(100 %)
2 diff
(99.8 %id)
AI751132 Bone, Hip .i 289 to 748 467 to 8       460/467
(98 %)
0 diff
(100 %id)
CA415094 Chondrosarcoma Grade II, Left Pelvis .i 306 to 1057 768 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 753/750
(100 %)
6 diff
(99.2 %id)
BQ007974 Chondrosarcoma, Left Pelvis .i 307 to 1057 766 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 750/751
(99 %)
3 diff
(99.7 %id)
CA412510 Chondrosarcoma Grade II, Left Pelvis .i 307 to 1016 727 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 709/709
(100 %)
1 diff
(99.9 %id)
CA412517 Chondrosarcoma Grade II, Left Pelvis .i 318 to 1055 757 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 739/739
(100 %)
2 diff
(99.8 %id)
AA775384 whole brain .j 1 to 377 377 to 1 P29S Q30* tiling clone,   377/377
(100 %)
3 diff
(99.3 %id)
BM782674 stomach .k 1 to 294 1 to 294 exact tiling clone, AAA   294/294
(100 %)
0 diff
(100 %id)
BM782714 stomach .k 1 to 294 1 to 294 exact AAA   294/294
(100 %)
0 diff
(100 %id)
BM836185 stomach .k 1 to 294 1 to 295 E33G R34K G35R L36S P37S ... tiling clone, AAA   295/295
(100 %)
1 diff
(99.7 %id)
BQ576114 Chondrosarcoma Grade II, Left Pelvis .l-u 1 to 712 730 to 19 exact tiling clone, AAA   712/712
(100 %)
5 diff
(99.3 %id)
AA357976 lung .m-u 1 to 306 307 to 1 S35X S37X tiling clone,   307/307
(100 %)
1 diff
(99.7 %id)
CN479608 Chondrosarcoma, Left Pubic Bone Gene COL11A1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BQ574979 Chondrosarcoma Grade II, Left Pelvis Gene COL11A1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DB355055 whole embryo, mainly head Gene COL11A1, variant not shown         This clone was ignored    
AU117295 whole embryo, mainly head Gene COL11A1, variant not shown       capped This clone was ignored    
AA329414   Gene COL11A1, variant not shown         This clone was ignored    
W31189 senescent fibroblast Gene COL11A1, variant not shown         Suspected internal deletion, this clone was ignored    
BI495676 cochlea, ear Gene COL11A1, variant not shown       AAA This clone was ignored    
BI495677 cochlea, ear Gene COL11A1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI